Exploring the impact of digital care delivery for patients with diabetes and hypertension: A longitudinal qualitative study

• by Matthew D. Dalstrom, Colleen J. Klein, Deanna Latino, Melinda Cooling

• May 12, 2026

Dapagliflozin and linagliptin combination therapy improves time in range and reverses hepatic steatosis in patients with type 2 diabetes and hypertension

• by WenXia Li, RuRan Li, ShanShan Li, Zhen Li, JingSu Ma, Fei Wu, ChaoQin Chen

• May 11, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min